Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results
Global Heart · 2023
DOI: 10.5334/gh.1272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Heart, 2023. Verfasst von Juan Esteban Gomez-Mesa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Fundación Valle del Lili, Cali, CO. Hauptthemen laut MEDLINE: Cardiovascular Diseases, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Socioeconomic factors contribute to a more severe impact of COVID-19 in Latin American and Caribbean (LA&C) countries than in developed countries. Patients with a severe or critical illness can develop respiratory and cardiovascular complications.
Objective
To describe a LA&C population with COVID-19 to provide information related to this disease, in-hospital cardiovascular complications, and in-hospital mortality.
Methods
The CARDIO COVID-19–20 Registry is an observational, multicenter, prospective, and hospital-based registry of patients with confirmed COVID-19 infection that required in-hospital treatment in LA&C. Enrollment of patients started on May 01, 2020, and ended on June 30, 2021.
Results
The CARDIO COVID-19–20 Registry included 3260 patients from 44 institutions of 14 LA&C countries. 63.2% patients were male and median age was 61.0 years old. Most common comorbidities were overweight/obesity (49.7%), hypertension (49.0%), and diabetes mellitus (26.7%). Most frequent cardiovascular complications during hospitalization or reported at discharge were cardiac arrhythmia (9.1%), decompensated heart failure (8.5%), and pulmonary embolism (3.9%). The number of patients admitted to the Intensive Care Unit (ICU) was 1745 (53.5%), and median length of their stay at the ICU was 10.0 days. Support required in ICU included invasive mechanical ventilation (34.2%), vasopressors (27.6%), inotropics (10.3%), and vasodilators (3.7%). Rehospitalization after 30-day post discharge was 7.3%. In-hospital mortality and 30-day post discharge were 25.5% and 2.6%, respectively.
Conclusions
According to our findings, more than half of the LA&C population with COVID-19 assessed required management in ICU, with higher requirement of invasive mechanical ventilation and vasoactive support, resulting in a high in-hospital mortality and a considerable high 30-day post discharge rehospitalization and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fundación Valle del Lili, Cali, CO.
- Instituto de Cardiología J.F Cabral, Corrientes, AR.
- Hospital Santo Tomas, Ciudad de Panama, PA.
- Universidad Central de Venezuela, Caracas, VE.
- Servicios y Tecnología Cardiovascular de Guatemala S.A -Cardiosolutions, Ciudad de Guatemala, GT.
- Clínica Adventista Belgrano, Buenos Aires, AR.
ORCID-Profile: Juan Esteban Gomez-Mesa, Stephania Galindo, Manuela Escalante-Forero, Yorlany Rodas, Andrea Valencia, Eduardo Perna, Alexander Romero, Iván Mendoza, Fernando Wyss, José Luis Barisani, Mario Speranza, Walter Alarco, Noel Alberto Flórez
Zitieren
APA
Gomez-Mesa, J. E., Galindo, S., Escalante-Forero, M., Rodas, Y., Valencia, A., Perna, E., Romero, A., Mendoza, I., Wyss, F., Barisani, J. L., Speranza, M., Alarco, W., & Flórez, N. A. (2023). Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results. Global Heart. https://doi.org/10.5334/gh.1272
Vancouver
Gomez-Mesa JE, Galindo S, Escalante-Forero M, Rodas Y, Valencia A, Perna E, et al. Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results. Global Heart. 2023. doi:10.5334/gh.1272
BibTeX
@article{GomezMesa2023,
author = {Gomez-Mesa, Juan Esteban and Galindo, Stephania and Escalante-Forero, Manuela and Rodas, Yorlany and Valencia, Andrea and Perna, Eduardo and Romero, Alexander and Mendoza, Iván and Wyss, Fernando and Barisani, José Luis and Speranza, Mario and Alarco, Walter and Flórez, Noel Alberto},
title = {Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results},
journal = {Global Heart},
year = {2023},
doi = {10.5334/gh.1272}
}
EUVIMED